Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free DHT.UN Stock Alerts

DRI Healthcare Trust (DHT.UN) Competitors

DRI Healthcare Trust logo
C$18.55 0.00 (0.00%)
As of 06/12/2026 04:00 PM Eastern
Compare

DHT.UN vs. BHC, CRON, THCX, GUD, and TLRY

Should you buy DRI Healthcare Trust stock or one of its competitors? MarketBeat compares DRI Healthcare Trust with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with DRI Healthcare Trust include Bausch Health Companies (BHC), Cronos Group (CRON), Hydropothecary (THCX), Knight Therapeutics (GUD), and Tilray Brands (TLRY). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does DRI Healthcare Trust compare to Bausch Health Companies?

DRI Healthcare Trust (TSE:DHT.UN) and Bausch Health Companies (TSE:BHC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

DRI Healthcare Trust presently has a consensus price target of C$25.50, indicating a potential upside of 37.47%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, research analysts plainly believe DRI Healthcare Trust is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Bausch Health Companies. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Bausch Health Companies. DRI Healthcare Trust's average media sentiment score of 1.16 beat Bausch Health Companies' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Overall Sentiment
DRI Healthcare Trust Positive
Bausch Health Companies Neutral

DRI Healthcare Trust has higher earnings, but lower revenue than Bausch Health Companies. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$163.77M6.23C$9.73M-C$0.90N/A
Bausch Health CompaniesC$10.53B0.25-C$125.65M-C$3.24N/A

DRI Healthcare Trust has a net margin of 5.02% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat DRI Healthcare Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Bausch Health Companies -13.54%120.43%4.16%

DRI Healthcare Trust has a beta of 0.472401, suggesting that its share price is 53% less volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.942978, suggesting that its share price is 6% less volatile than the broader market.

0.6% of DRI Healthcare Trust shares are owned by institutional investors. Comparatively, 11.0% of Bausch Health Companies shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by insiders. Comparatively, 11.3% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

DRI Healthcare Trust beats Bausch Health Companies on 10 of the 16 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Cronos Group?

Cronos Group (TSE:CRON) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation.

DRI Healthcare Trust has a net margin of 5.02% compared to Cronos Group's net margin of -1.29%. DRI Healthcare Trust's return on equity of 2.06% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-1.29% -0.19% -3.73%
DRI Healthcare Trust 5.02%2.06%4.22%

Cronos Group has a beta of 1.134248, meaning that its share price is 13% more volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.472401, meaning that its share price is 53% less volatile than the broader market.

DRI Healthcare Trust has higher revenue and earnings than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$159.54M8.81-C$32.78MN/AN/A
DRI Healthcare TrustC$163.77M6.23C$9.73M-C$0.90N/A

Cronos Group presently has a consensus price target of C$4.75, indicating a potential upside of 26.33%. DRI Healthcare Trust has a consensus price target of C$25.50, indicating a potential upside of 37.47%. Given DRI Healthcare Trust's higher possible upside, analysts plainly believe DRI Healthcare Trust is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

4.6% of Cronos Group shares are held by institutional investors. Comparatively, 0.6% of DRI Healthcare Trust shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Cronos Group. DRI Healthcare Trust's average media sentiment score of 1.16 beat Cronos Group's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Cronos Group Neutral
DRI Healthcare Trust Positive

Summary

DRI Healthcare Trust beats Cronos Group on 9 of the 13 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Hydropothecary?

Hydropothecary (CVE:THCX) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Hydropothecary. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Hydropothecary. DRI Healthcare Trust's average media sentiment score of 1.16 beat Hydropothecary's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Hydropothecary Neutral
DRI Healthcare Trust Positive

0.6% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

DRI Healthcare Trust has a net margin of 5.02% compared to Hydropothecary's net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Hydropothecary's return on equity.

Company Net Margins Return on Equity Return on Assets
HydropothecaryN/A N/A N/A
DRI Healthcare Trust 5.02%2.06%4.22%

DRI Healthcare Trust has higher revenue and earnings than Hydropothecary.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HydropothecaryN/AN/AN/AN/AN/A
DRI Healthcare TrustC$163.77M6.23C$9.73M-C$0.90N/A

DRI Healthcare Trust has a consensus target price of C$25.50, indicating a potential upside of 37.47%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, analysts clearly believe DRI Healthcare Trust is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

DRI Healthcare Trust beats Hydropothecary on 11 of the 11 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Knight Therapeutics?

Knight Therapeutics (TSE:GUD) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Knight Therapeutics presently has a consensus target price of C$9.50, indicating a potential upside of 0.21%. DRI Healthcare Trust has a consensus target price of C$25.50, indicating a potential upside of 37.47%. Given DRI Healthcare Trust's higher possible upside, analysts clearly believe DRI Healthcare Trust is more favorable than Knight Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Knight Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

DRI Healthcare Trust has lower revenue, but higher earnings than Knight Therapeutics. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Knight TherapeuticsC$510.45M1.82-C$30.73MC$0.06158.00
DRI Healthcare TrustC$163.77M6.23C$9.73M-C$0.90N/A

Knight Therapeutics has a beta of -0.141784, suggesting that its stock price is 114% less volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.472401, suggesting that its stock price is 53% less volatile than the broader market.

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Knight Therapeutics. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Knight Therapeutics. DRI Healthcare Trust's average media sentiment score of 1.16 beat Knight Therapeutics' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Knight Therapeutics Neutral
DRI Healthcare Trust Positive

23.9% of Knight Therapeutics shares are held by institutional investors. Comparatively, 0.6% of DRI Healthcare Trust shares are held by institutional investors. 45.6% of Knight Therapeutics shares are held by company insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

DRI Healthcare Trust has a net margin of 5.02% compared to Knight Therapeutics' net margin of 1.10%. DRI Healthcare Trust's return on equity of 2.06% beat Knight Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Knight Therapeutics1.10% 0.73% 0.51%
DRI Healthcare Trust 5.02%2.06%4.22%

Summary

DRI Healthcare Trust beats Knight Therapeutics on 10 of the 15 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Tilray Brands?

DRI Healthcare Trust (TSE:DHT.UN) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

DRI Healthcare Trust has a beta of 0.472401, meaning that its share price is 53% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.007995, meaning that its share price is 201% more volatile than the broader market.

In the previous week, DRI Healthcare Trust and DRI Healthcare Trust both had 2 articles in the media. DRI Healthcare Trust's average media sentiment score of 1.16 beat Tilray Brands' score of 0.07 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DRI Healthcare Trust
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

DRI Healthcare Trust has higher earnings, but lower revenue than Tilray Brands. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$163.77M6.23C$9.73M-C$0.90N/A
Tilray BrandsC$858.28M0.98-C$183.24M-C$14.63N/A

DRI Healthcare Trust presently has a consensus price target of C$25.50, suggesting a potential upside of 37.47%. Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 91.09%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than DRI Healthcare Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

DRI Healthcare Trust has a net margin of 5.02% compared to Tilray Brands' net margin of -158.75%. DRI Healthcare Trust's return on equity of 2.06% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Tilray Brands -158.75%-88.06%-1.41%

0.6% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.4% of Tilray Brands shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Comparatively, 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

DRI Healthcare Trust beats Tilray Brands on 9 of the 15 factors compared between the two stocks.

Get DRI Healthcare Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHT.UN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHT.UN vs. The Competition

Export
MetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$1.02BC$2.39BC$6.52BC$12.19B
Dividend Yield3.12%2.94%2.67%6.19%
P/E Ratio-20.615.0124.0036.94
Price / Sales6.231,642.95514.3610.45
Price / CashN/A10.1827.4882.29
Price / Book1.9910.6110.544.47
Net IncomeC$9.73MC$20.27BC$3.57BC$299.09M
7 Day Performance2.32%-0.80%0.60%0.65%
1 Month Performance14.93%6.97%1.56%-0.08%
1 Year Performance39.16%16.05%25.42%41.90%

DRI Healthcare Trust Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHT.UN
DRI Healthcare Trust
2.9387 of 5 stars		C$18.55
flat		C$25.50
+37.5%		+39.2%C$1.02BC$163.77MN/AN/A
BHC
Bausch Health Companies
0.3615 of 5 stars		C$7.49
+2.5%		N/A-12.7%C$2.73BC$10.53BN/A19,900
CRON
Cronos Group
2.0585 of 5 stars		C$3.85
-1.3%		C$4.75
+23.4%		+43.0%C$1.46BC$159.54MN/A450
THCX
Hydropothecary
N/AC$5.30
+6.6%		N/A+0.0%C$949.11MN/AN/AN/A
GUD
Knight Therapeutics
0.2835 of 5 stars		C$8.61
+1.8%		C$9.50
+10.3%		+57.2%C$845.32MC$510.45M143.50725

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:DHT.UN) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel